510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K915602Substantially Equivalent

Sri Digoxin Enzyme Immunoassay

Serono-Baker Diagnostics, Inc., Allentown PA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K915602 is the FDA 510(k) clearance record for SRI DIGOXIN ENZYME IMMUNOASSAY, a class II device, cleared for Serono-Baker Diagnostics, Inc. on under FDA product code KXT (Enzyme Immunoassay, Digoxin). FDA records list 23 510(k) clearances for Serono-Baker Diagnostics, Inc., from to . As of , FDA records show no recalls naming K915602.

Clearance record

Decision date
Received
(35 days to decision)
Product code
KXT Enzyme Immunoassay, Digoxin
Regulation
21 CFR 862.3320
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Serono-Baker Diagnostics, Inc. 100 Cascade Dr., Allentown PA
510(k) summary
Statement
Third party review
No

Clearances, product code KXT

Trailing 12 months

FDA records hold no clearances under product code KXT in the trailing twelve months.

FDA records show no clearances under product code KXT in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code KXT, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260